These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 12669348)

  • 1. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
    Famin O; Ginsburg H
    Parasite; 2003 Mar; 10(1):39-50. PubMed ID: 12669348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroartemisinin-Ferriprotoporphyrin IX Adduct Abundance in Plasmodium falciparum Malarial Parasites and the Relationship to Emerging Artemisinin Resistance.
    Heller LE; Goggins E; Roepe PD
    Biochemistry; 2018 Dec; 57(51):6935-6945. PubMed ID: 30512926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs.
    Famin O; Krugliak M; Ginsburg H
    Biochem Pharmacol; 1999 Jul; 58(1):59-68. PubMed ID: 10403519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum.
    Bray PG; Janneh O; Raynes KJ; Mungthin M; Ginsburg H; Ward SA
    J Cell Biol; 1999 Apr; 145(2):363-76. PubMed ID: 10209030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes.
    Famin O; Ginsburg H
    Biochem Pharmacol; 2002 Feb; 63(3):393-8. PubMed ID: 11853690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum.
    Radfar A; Diez A; Bautista JM
    Free Radic Biol Med; 2008 Jun; 44(12):2034-42. PubMed ID: 18397762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Meierjohann S; Walter RD; Müller S
    Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of malarial parasites and erythrocytes by ferriprotoporphyrin IX-chloroquine and the inhibition of this effect by proteins.
    Zhang Y; Hempelmann E
    Biochem Pharmacol; 1987 Apr; 36(8):1267-73. PubMed ID: 3297071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine - some open questions on its antimalarial mode of action and resistance.
    Ginsburg H; Krugliak M
    Drug Resist Updat; 1999 Jun; 2(3):180-187. PubMed ID: 11504489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms for Drug Hypersensitivity Induced by the Malaria Parasite's Chloroquine Resistance Transporter.
    Richards SN; Nash MN; Baker ES; Webster MW; Lehane AM; Shafik SH; Martin RE
    PLoS Pathog; 2016 Jul; 12(7):e1005725. PubMed ID: 27441371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of Free Ferriprotoporphyrin IX Heme and Hemozoin for Artemisinin Sensitive versus Delayed Clearance Phenotype Plasmodium falciparum Malarial Parasites.
    Heller LE; Roepe PD
    Biochemistry; 2018 Dec; 57(51):6927-6934. PubMed ID: 30513202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
    Ellekvist P; Colding H
    Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs.
    Zhang J; Krugliak M; Ginsburg H
    Mol Biochem Parasitol; 1999 Mar; 99(1):129-41. PubMed ID: 10215030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme binding contributes to antimalarial activity of bis-quaternary ammoniums.
    Biagini GA; Richier E; Bray PG; Calas M; Vial H; Ward SA
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2584-9. PubMed ID: 12878523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of antimalarial drugs.
    Fitch CD
    Ciba Found Symp; 1983; 94():222-32. PubMed ID: 6341003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characteristics of the malaria parasite's "chloroquine resistance transporter": implications for chemotherapy.
    Summers RL; Martin RE
    Virulence; 2010; 1(4):304-8. PubMed ID: 21178460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diamidine compounds: selective uptake and targeting in Plasmodium falciparum.
    Stead AM; Bray PG; Edwards IG; DeKoning HP; Elford BC; Stocks PA; Ward SA
    Mol Pharmacol; 2001 May; 59(5):1298-306. PubMed ID: 11306715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium.
    Ginsburg H; Golenser J
    Redox Rep; 2003; 8(5):276-9. PubMed ID: 14962364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.
    Edaye S; Reiling SJ; Leimanis ML; Wunderlich J; Rohrbach P; Georges E
    Mol Biochem Parasitol; 2014 Jun; 195(1):34-42. PubMed ID: 24914817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of malaria parasite growth by quinomycin A and its derivatives through DNA-intercalating activity.
    Hayase H; Watanabe N; Lim CL; Nogawa T; Komatsuya K; Kita K; Osada H
    Biosci Biotechnol Biochem; 2015; 79(4):633-5. PubMed ID: 25471083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.